Glucagon secretion from pancreatic α-cells

Upsala Journal of Medical Sciences

Volumn 121, Issue 2, 2016, Pages 113-119

  Briant, Linford ^a   Salehi, Albert ^b   Vergari, Elisa ^a   Zhang, Quan ^a   Rorsman, Patrik ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

diabetes; electrophysiology; experimental diabetes; glucagon; intrinsic mechanisms; pancreatic alpha cells; paracrine

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

ANIMAL; BLOOD; ELECTROPHYSIOLOGY; HUMAN; HYPERGLYCEMIA; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; RAT; SECRETION (PROCESS); SIGNAL TRANSDUCTION; THEORETICAL MODEL;

ANIMALS; DIABETES MELLITUS, TYPE 2; ELECTROPHYSIOLOGY; GLUCAGON; GLUCAGON-SECRETING CELLS; GLUCOSE; HUMANS; HYPERGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; MICE; MODELS, THEORETICAL; RATS; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; SOMATOSTATIN;

EID: 84962406727     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2016.1156789     Document Type: Review

References (70)

1. F.G.Banting, C.H.Best, J.B.Collip, W.R.Campbell, A.A.Fletcher Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 1922;12:141–6.
2. J.R.Murlin, H.D.Clough, C.B.F.Gibbs, A.M.Stokes Aqueous extracts of the pancreas. 1. Influence on the carbohydrate metabolism of depancreatized animals. J Biol Chem 1923;56:253–96.
3. E.W.Sutherland, C.De Duve Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas. J Biol Chem 1948;175:663–74.
4. P.P.Foa, G.Galansino, G.Pozza Glucagon, a second pancreatic hormone. Recent Prog Horm Res 1957;13:473–503; discussion 503–10.
5. P.P.Foa, H.R.Weinstein, J.A.Smith Secretion of insulin and of a hyperglycemic substance studied by means of pancreatic-femoral cross-circulation experiments. Am J Physiol 1949;157:197–204.
6. P.E.Lins, A.Wajngot, U.Adamson, M.Vranic, S.Efendic Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia. Diabetes 1983;32:633–6.
7. S.E.Kahn, S.Zraika, K.M.Utzschneider, R.L.Hull The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009;52:1003–12.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32(Suppl 1):S62–7.
9. E.Ginter, V.Simko Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol 2012;771:42–50.
10. M.Murea, L.Ma, B.I.Freedman Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud 2012;9:6–22.
11. M.Prentki, C.J.Nolan Islet beta cell failure in type 2 diabetes. J Clin Invest 2006;116:1802–12.
12. D.D'Alessio The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes Obes Metab 2011;13(Suppl 1):126–32.
13. B.E.Dunning, J.E.Foley, B.Ahren Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 2005;48:1700–13.
14. R.H.Unger, A.D.Cherrington Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest 2012;122:4–12.
15. P.E.Cryer Glucagon and hyperglycaemia in diabetes. Clin Sci (Lond) 2008;114:589–90.
16. P.E.Cryer Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 2002;45:937–48.
17. P.Rorsman, E.Renstrom Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003;46:1029–45.
18. F.M.Ashcroft, P.Rorsman Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 1989;54:87–143.
19. F.Ashcroft, P.Rorsman Type 2 diabetes mellitus: not quite exciting enough? Hum Mol Genet 2004;13:R21–31.
20. J.Gromada, I.Franklin, C.B.Wollheim Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 2007;28:84–116.
21. E.Gylfe Glucose control of glucagon secretion: there is more to it than K-ATP channels. Diabetes 2013;62:1391–3.
22. E.Gylfe, P.Gilon Glucose regulation of glucagon secretion. Diabetes Res Clin Pract 2014;103:1–10.
23. I.Franklin, J.Gromada, A.Gjinovci, S.Theander, C.B.Wollheim Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 2005;54:1808–15.
24. H.L.Olsen, S.Theander, K.Bokvist, K.Buschard, C.B.Wollheim, J.Gromada Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells. Endocrinology 2005;146:4861–70.
25. C.G.Ostenson Regulation of glucagon release: effects of insulin on the pancreatic A2-cell of the guinea pig. Diabetologia 1979;17:325–30.
26. A.Reetz, M.Solimena, M.Matteoli, F.Folli, K.Takei, P.De Camilli GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 1991;10:1275–84.
27. P.Rorsman, P.O.Berggren, K.Bokvist, H.Ericson, H.Mohler, C.G.Ostenson, et al. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 1989;341:233–6.
28. H.Ishihara, P.Maechler, A.Gjinovci, P.L.Herrera, C.B.Wollheim Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 2003;5:330–5.
29. H.Zhou, T.Zhang, J.S.Harmon, J.Bryan, R.P.Robertson Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes 2007;56:1107–12.
30. M.A.Ravier, G.A.Rutter Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes 2005;54:1789–97.
31. T.J.Nicolson, E.A.Bellomo, N.Wijesekara, M.K.Loder, J.M.Baldwin, A.V.Gyulkhandanyan, et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 2009;58:2070–83.
32. H.Johansson, E.Gylfe, B.Hellman Cyclic AMP raises cytoplasmic calcium in pancreatic alpha 2-cells by mobilizing calcium incorporated in response to glucose. Cell Calcium 1989;10:205–11.
33. D.G.Pipeleers, F.C.Schuit, C.F.Van Schravendijk, M.Van de Winkel Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 1985;117:817–23.
34. J.N.Walker, R.Ramracheya, Q.Zhang, P.R.Johnson, M.Braun, P.Rorsman Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? Diabetes Obes Metab 2011;13(Suppl 1):95–105.
35. A.Starke, T.Imamura, R.H.Unger Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration. J Clin Invest 1987;79:20–4.
36. L.J.Klaff, G.J.Taborsky Pancreatic somatostatin is a mediator of glucagon-inhibition by hyperglycemia. Diabetes 1987;36:592–6.
37. K.Cejvan, D.H.Coy, S.Efendic Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. Diabetes 2003;52:1176–81.
38. M.Z.Strowski, R.M.Parmar, A.D.Blake, J.M.Schaeffer Somatostatin inhibits insulin and glucagon secretion via two receptor subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 2000;141:111–17.
39. B.Kailey, M.van de Bunt, S.Cheley, P.R.Johnson, P.E.MacDonald, A.L.Gloyn, et al. SSTR2 is the functionally dominant somatostatin receptor in human pancreatic beta- and alpha-cells. Am J Physiol Endocrinol Metab 2012;303:E1107–16.
40. A.D.Elliott, A.Ustione, D.W.Piston Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic alpha-cell by lowering cAMP. Am J Physiol Endocrinol Metab 2015;308:E130–43.
41. A.C.Hauge-Evans, A.J.King, D.Carmignac, C.C.Richardson, I.C.A.F.Robinson, M.J.Low, et al. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009;58:403–11.
42. E.Vieira, A.Salehi, E.Gylfe Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells. Diabetologia 2007;50:370–9.
43. R.Cheng-Xue, A.Gomez-Ruiz, N.Antoine, L.A.Noel, H.Y.Chae, M.A.Ravier, et al. Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of K(ATP) channels from both alpha-cells and delta-cells. Diabetes 2013;62:1612–22.
44. J.de Heer, C.Rasmussen, D.H.Coy, J.J.Holst Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 2008;51:2263–70.
45. J.Gromada, X.Ma, M.Hoy, K.Bokvist, A.Salehi, P.O.Berggren, et al. ATP-sensitive K + channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse alpha-cells. Diabetes 2004;53(Suppl 3):S181–9.
46. Q.Zhang, R.Ramracheya, C.Lahmann, A.Tarasov, M.Bengtsson, O.Braha, et al. Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes. Cell Metab 2013;18:871–82.
47. Q.Zhang, M.V.Chibalina, M.Bengtsson, L.N.Groschner, R.Ramracheya, N.J.Rorsman, et al. Na + current properties in islet alpha- and beta-cells reflect cell-specific Scn3a and Scn9a expression. J Physiol 2014;592:4677–96.
48. P.E.MacDonald, Y.Z.De Marinis, R.Ramracheya, A.Salehi, X.S.Ma, P.R.V.Johnson, et al. A K-ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol 2007;5:1236–47.
49. Y.Z.De Marinis, E.Zhang, S.Amisten, J.Taneera, E.Renstrom, P.Rorsman, et al. Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCalpha and PKCdelta. Diabetologia 2010;53:717–29.
50. Y.Z.De Marinis, A.Salehi, C.E.Ward, Q.Zhang, F.Abdulkader, M.Bengtsson, et al. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab 2010;11:543–53.
51. S.Barg, J.Galvanovskis, S.O.Gopel, P.Rorsman, L.Eliasson Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes 2000;49:1500–10.
52. C.Bonner, J.Kerr-Conte, V.Gmyr, G.Queniat, E.Moerman, J.Thevenet, et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med 2015;21:512–17.
53. C.S.Hummel, C.Lu, D.D.Loo, B.A.Hirayama, A.A.Voss, E.M.Wright Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2. Am J Physiol Cell Physiol 2011;300:C14–21.
54. Y.J.Liu, E.Vieira, E.Gylfe A store-operated mechanism determines the activity of the electrically excitable glucagon-secreting pancreatic alpha-cell. Cell Calcium 2004;35:357–65.
55. P.K.Dadi, B.Luo, N.C.Vierra, D.A.Jacobson TASK-1 potassium channels limit pancreatic alpha-cell calcium influx and glucagon secretion. Mol Endocrinol 2015;29:777–87.
56. S.J.Le Marchand, D.W.Piston Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets. J Biol Chem 2010;285:14389–98.
57. X.Q.Dai, A.F.Spigelman, S.Khan, M.Braun, J.E.Manning Fox, P.E.MacDonald SUMO1 enhances cAMP-dependent exocytosis and glucagon secretion from pancreatic alpha-cells. J Physiol 2014;592:3715–26.
58. J.M.Epstein Why model? Journal of Artificial Societies and Social Simulation 2008;11:12. https://protect-us.mimecast.com/s/Y1zJBRt699ndi5
59. M.Watts, A.Sherman Modeling the pancreatic alpha-cell: dual mechanisms of glucose suppression of glucagon secretion. Biophys J 2014;106:741–51.
60. F.Montefusco, M.G.Pedersen Mathematical modelling of local calcium and regulated exocytosis during inhibition and stimulation of glucagon secretion from pancreatic alpha-cells. J Physiol 2015;593:4519–30.
61. L.E.Fridlyand, L.H.Philipson A computational systems analysis of factors regulating alpha cell glucagon secretion. Islets 2012;4:262–83.
62. P.M.Diderichsen, S.O.Gopel Modelling the electrical activity of pancreatic alpha-cells based on experimental data from intact mouse islets. J Biol Phys 2006;32:209–29.
63. M.Fink, W.R.Giles, D.Noble Contributions of inwardly rectifying K + currents to repolarization assessed using mathematical models of human ventricular myocytes. Philos Trans A Math Phys Eng Sci 2006;364:1207–22.
64. P.E.Cryer, S.N.Davis, H.Shamoon Hypoglycemia in diabetes. Diabetes Care 2003;26:1902–12.
65. J.T.Yue, E.Burdett, D.H.Coy, A.Giacca, S.Efendic, M.Vranic Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats. Diabetes 2012;61:197–207.
66. N.Karimian, T.Qin, T.Liang, M.Osundiji, Y.Huang, T.Teich, et al. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats. Diabetes 2013;62:2968–77.
67. J.Rahier, R.M.Goebbels, J.C.Henquin Cellular composition of the human diabetic pancreas. Diabetologia 1983;24:366–71.
68. G.Kilimnik, B.Zhao, J.H.Jo, V.Periwal, P.Witkowski, R.Misawa, et al. Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes. PLoS One 2011;6:e27445.
69. A.Clark, C.A.Wells, I.D.Buley, J.K.Cruickshank, R.I.Vanhegan, D.R.Matthews,. Islet amyloid, increased a-cells, reduced B-Cells and exocrine fibrosis - quantitative changes in the pancreas in type-2 diabetes. Diabetes Res 1988;9:151–9.
70. M.F.Brereton, E.Vergari, Q.Zhang, A.Clark Alpha-, delta- and PP-cells: are they the architectural cornerstones of islet structure and co-ordination? J Histochem Cytochem 2015;63:575–91.